PlainRecalls
FDA Drug Moderate Class II Terminated

GaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873, USA Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-060-19

Reported: August 25, 2021 Initiated: July 29, 2021 #D-0726-2021

Product Description

GaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873, USA Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-060-19

Reason for Recall

Failed Stability Specification; Out of specification for Osmolarity

Details

Units Affected
20,814 bottles
Distribution
Nationwide
Location
Somerset, NJ

Frequently Asked Questions

What product was recalled?
GaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873, USA Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-060-19. Recalled by Novel Laboratories, Inc. d.b.a LUPIN. Units affected: 20,814 bottles.
Why was this product recalled?
Failed Stability Specification; Out of specification for Osmolarity
Which agency issued this recall?
This recall was issued by the FDA Drug on August 25, 2021. Severity: Moderate. Recall number: D-0726-2021.